Houston Methodist first in the nation to be approved by FDA to transfuse donated plasma from recovered COVID-19 patient
HOUSTON – Houston Methodist Hospital will be the first academic medical center in the country to transfuse donated plasma from a recovered COVID-19 patient to a critically-ill COVID-19 patient. “What we did is transfused COVID-19 convalescent plasma to two critically ill patients,” said Dr. Eric Salazar, the principal investigator and a physician-scientist at Houston Methodist.
You must be logged in to post a comment.